Search for Clinical Trial Results
Gastrinoma - 25 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery Condition:
Date: 2010-10-27 Interventions: |
Withdrawn |
Study Name: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors Condition:
|
Completed |
Study Name: A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases Condition:
|
Terminated |
Study Name: Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery Condition:
|
Active, not recruiting |
Study Name: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Condition:
|
Active, not recruiting |
Study Name: Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors Condition:
|
Recruiting |
Study Name: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors Condition:
|
Active, not recruiting |
Study Name: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors Condition:
|
Completed |
Study Name: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors Condition:
|
Terminated |
Study Name: Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors Condition:
|